Objective-The expression of ephrinB2 in endothelial cells delineates their arterial phenotype and is a prerequisite for the development of the embryonic vasculature. Whereas the role of ephrinB2 in the microcirculation has been studied extensively, its expression and function in adult arteries is hardly understood. Methods and Results-Our analyses showed that in mouse arteries, ephrinB2 is located on the luminal surface of endothelial cells and may physically interact with monocyte EphB receptors. Moreover, transdifferentiation of human monocytes into macrophages was associated with an increase in EphB2 expression, and exposing monocytes to immobilized ephrinB2 resulted in phosphorylation of the receptor followed by an increased expression of proinflammatory chemokines such as interleukin-8 and monocyte chemotactic protein-1/CCL2. Relating to the (patho)physiological relevance of these findings, immunofluorescence analyses revealed that ephrinB2 is most abundantly expressed in endothelial cells at arteriosclerosis predilection sites of the mouse aorta. Subsequent analyses indicated that monocyte adhesion to aortic segments abundantly expressing ephrinB2 is strongly enhanced and that endothelial cell ephrinB2 forward signaling is sufficient to upregulate cytokine expression in monocytes. 
phrinB2 belongs to a group of membrane-associated ligands that bind to the largest family of receptor tyrosine kinases, the Eph receptors. 1 Genetic deficiency and loss-offunction mutations of ephrinB2 in mice lead to early embryonic lethality due to severe defects in arteriovenous differentiation. [2] [3] [4] Similarly, mice deficient in ephrinB2 receptors EphB2, EphB3, and EphB4 all display more or less severe vasculogenesis defects, with EphB4-deficient mice copying the phenotype of ephrinB2 knockout animals. 4 Although the ephrinB/EphB system has been established as an important determinant of vasculogenesis and angiogenesis, [5] [6] [7] it may also have a function in leukocyte activation. For instance, whereas EphB6-null mutations adversely affect T-cell function, 8, 9 ephrinB2 can act as a costimulatory molecule for T cells inducing interferon-␥ release. 10 Moreover, functionally interfering with the ephrinB/EphB system impedes monocyte transmigration through an endothelial cell monolayer, 11, 12 highlighting the potential pathophysiological relevance of ephrinB2-mediated endothelial cell-monocyte interactions.
However, whereas regulatory mechanisms have been characterized in some detail 4, 13 -particularly vascular endothelial cell growth factor signaling controlling ephrinB2 expression in angiogenic endothelial cells-much less is known about ephrinB2 regulation and function in adult arteries. In this context, an increasing body of evidence suggests that endothelial cell ephrinB2 expression is affected by hemodynamic forces, such as laminar shear stress, which downregulates it in human endothelial cells. 14 In contrast, endothelial cells exposed to an increased level of stretch upregulate ephrinB2 expression, 11 and it is this hemodynamic force that is thought to be pivotal in arteriosclerosis. 15 Arteriosclerosis is a chronic proinflammatory disease that primarily develops at arterial bifurcations or curvatures where nonlaminar blood flow and rhythmic distension of the vessel wall promote endothelial dysfunction, a hallmark in the formation of early arteriosclerotic lesions. 16, 17 Although individual steps of arteriosclerotic plaque progression seem to have been deciphered, the molecular mechanisms promoting the switch from endothelial cell dysfunction to lesion development at arteriosclerosis predilection sites remain to be elucidated. Dysfunctional endothelial cells apparently upregulate expression of adhesion molecules such as vascular cell adhesion molecule-1, which subsequently facilitate the infiltration of the vessel wall by circulating leukocytes. These immune cells in turn amplify the local inflammation by releasing proinflammatory chemokines and cytokines, thus accelerating progression of the disease. Interestingly, the initial steps of arteriosclerosis resemble those at the onset of arteriogenesis, a biomechanically induced adaptive remodeling process of collateral arterioles that is accompanied by an upregulation of endothelial cell ephrinB2 expression. 11, 18 The apparently stimulating effects of ephrinB2 on monocytes and the association between proinflammatory arterial remodeling and augmented endothelial cell ephrinB2 expression prompted us-despite some technical challenges-to investigate its effects on monocyte function. Herein, we report that ephrinB2 facilitates the proinflammatory activation of EphB receptor-expressing monocytes and is upregulated in endothelial cells at arteriosclerosis-prone sites-2 effects that would promote the site-specific development of arteriosclerotic lesions.
Materials and Methods
See Supplemental Materials and Methods, available online at http:// atvb.ahajournals.org. This expanded section includes a detailed description of the recombinant ephrinB2 protein used throughout the study (supplement material and Supplemental Figure I ).
Materials
Recombinant ephrinB2 was purchased from GenWay Biotech (San Diego, Calif). The EphB2, EphB3, EphB4, and ephrinB2 antibodies were from R&D Systems (Wiesbaden, Germany).
Single-Cell Force Spectroscopy
Single human premonocytic cell line THP-1 (human acute monocytic leukemia cell line) cells were attached to the cantilever of an atomic force microscope and pressed onto a bovine serum albumin (BSA)-or ephrinB2-coated surface with a defined force of 1 nN. A constant force was maintained for 30 seconds before the cantilever's direction of movement was reversed and the cells were detached from the surface. The number of unbinding events needed to detach the cells from the coat was determined as described previously. 12 
Ex Vivo Adhesion of Cultured Monocytes to Native Endothelial Cells
The thoracic aorta and a branch of the mesenteric artery of adult Naval Medical Research Institute (NMRI) mice were used for these experiments. Calceinacetoxymethylester (Calcein AM) labeled THP-1 cells were injected into isolated arteries and allowed to interact with the vessel wall for 5 minutes. Thereafter they were briefly rinsed, fixed in 4% formaldehyde and the number of firmly attached THP-1 cells counted by using a fluorescence microscope. To inhibit ephrinB2/EphB-mediated endothelial cell-THP-1 cell interaction, the suspended THP-1 cells or isolated aortas were preincubated for 1 hour with 4 g/mL soluble ephrinB2 or EphB4, respectively.
Activation of THP-1 Cells and Human Monocytes
Suspended THP-1 cells or human monocytes isolated from buffy coat and purified by CD14-magnetic bead selection were incubated on ephrinB2-or BSA-coated surfaces (approximately 0.07 g/cm 2 ) for 5 hours (mRNA analyses) or 18 hours (cytokine array), respectively. To inhibit ephrinB2/EphB-mediated activation, cells were preincubated for 1 hour with 4 g/mL soluble ephrinB2. To analyze EphB2 phosphorylation, THP-1 cells were incubated in the presence of 2 mmol/L orthovanadate for 1 hour. Cocultures of THP-1 and porcine aortic endothelial cells were performed for 18 hours.
Cytokine Array
Suspended THP-1 cells were cultured on BSA or ephrinB2-coated plates for 18 hours. Thereafter, supernatants were collected and freed from floating cells by centrifugation. Aliquots of the cleared supernatant were then analyzed by using the Human Antibody Cytokine Array III (Ray Biotech, Cologne, Germany) according to the manufacturer's instructions and quantified by densitometry.
Statistical Analysis
Results are expressed as meansϮSD. Differences between experimental groups were analyzed by the unpaired Student t test using the InStat 3.0 (GraphPad) or Statistica 5.1 (StatSoft) software, with PϽ0.05 considered statistically significant. The data from the single-cell force spectroscopy experiments was statistically analyzed by application of the Mann-Whitney rank sum test (U test). The threshold for significance was set to PϽ0.05.
Results

Expression of Monocytic EphB2 Is Upregulated on Monocyte Adhesion and Becomes Phosphorylated Through Interaction With EphrinB2
Whereas the Eph/ephrin system is investigated primarily with respect to its impact on neuronal growth and angiogenesis, previous findings indicate that (1) monocytes express EphB receptors 11, 12 and that (2) ephrinB2 affects their migratory activity (Supplemental Figure II) , as well as their transmigration through an endothelial cell monolayer. 11, 12 Because monocytes must adhere to get in contact with endothelial cell-associated ephrinB2, we first analyzed whether monocytes change their EphB expression profile on adhesion. To this end, freshly isolated human monocytes were allowed to adhere to cell culture plastic, promoting their differentiation into macrophages, as evidenced by the increase in CD68 expression 19 ( Figure 1A ). Unlike EphB1, EphB3, and EphB4 expression (data not shown), EphB2 expression in adherent monocytes was increased ( Figure 1A ), consistent with the finding that this EphB receptor is most prominently expressed even on suspended monocytes ( Figure 1B , 1C, and 1D).
To further investigate the impact of ephrinB2 on the monocyte phenotype, we used THP-1 cells for all subsequent experiments. This human monocyte cell line was chosen because it closely resembles the EphB expression pattern (Supplemental Figure III) and behavior of human monocytes but reacts more homogeneously to stimuli. With these cells, we investigated whether monocytes in principle are capable of physically interacting with ephrinB2. To this end, single THP-1 cells were attached to the cantilever of an atomic force microscope and then exposed to a glass surface homogenously coated with ephrinB2. By slowly moving the cantilever upward, the force required to detach the cell from the coating and the number of unbinding events ( Figure 1E )-equivalent to the breaking of a single ligand-receptor interaction-were determined subsequently. As shown in Figure  1F , there was a distinct physical interaction between the ephrinB2 coating and the monocytic EphB receptors, with approximately twice as many unbinding events compared with a BSA-coated surface.
Moreover, there was a distinct phosphorylation of EphB2 on exposure of suspended THP-1 cells to the ephrinB2 coat ( Figure 1G , upper panel). In contrast, exposure of suspended cells to soluble ephrinB2 resulted in neither a phosphoryla-tion of EphB2 (Figure G, lower panel) nor an appreciable change in proinflammatory gene expression (Supplemental Figure I ), highlighting the fact that only clustered (ie, coated) ephrinB2 is capable of exerting relevant EphB-mediated biological effects. 20, 21 EphrinB2-Activated Monocytes Release Monocyte Chemotactic Protein-1 and Interleukin-8
On the basis of the aforementioned findings, we hypothesized that ephrinB2 stimulation of monocytes/macrophages elicits a specific functional response. Subsequent DNA macroarray analyses revealed that coated ephrinB2 induces profound changes in arteriosclerosis-associated gene expression in the THP-1 cells (Supplemental Figure IV) . These data were confirmed in THP-1 cells and human monocytes by real-time polymerase chain reaction analyses revealing, inter alia, a significant upregulation of the proinflammatory chemokines monocyte chemotactic protein-1 (MCP-1)/CCL2 and inter- 
The Abundance of EphrinB2 Is Increased at Arteriosclerosis-Prone Sites
To evaluate the relevance of these in vitro findings, we performed a detailed immunohistochemical analysis of the mouse vasculature focusing on arterial segments that were exposed to decreased (laminar) shear stress and elevated (cyclic) stretch-hemodynamic forces that have been shown to control endothelial cell ephrinB2 expression in vitro. 11, 14 Semiquantitative mapping of ephrinB2 protein levels on an anatomic scheme of the aortic arch revealed a heterogeneous distribution, with strong expression along the inner curvature but weak expression along the outer curvature ( Figure 3A , 3C, and 3E; Supplemental Figure VI) . Interestingly, endothelial cell ephrinB2 expression seemingly coincided with sites of spontaneous arteriosclerotic plaque formation ( Figure 3B , 3D, and 3F) in the aortic arch of apolipoprotein E (ApoE)-deficient mice ( Figure 3A and 3B) . To assess the effect of an increase in wall tension (stretch) on ephrinB2 expression at arteriosclerosis-prone sites, aortic arch specimens of hypertensive (deoxycorticosterone acetate [DOCA]-salt treated) wild-type mice were subjected to immunofluorescence analyses as well. Hypertension resulted in a relative increase in ephrinB2 expression along the outer curvature as compared with the inner curvature of the aortic arch (compare Figure 3C and 3E with Figure 3G and 3H; Supplemental Figure VI) .
Arterial EphrinB2 Abundance Facilitates Interaction With EphB-Expressing Monocytes
Given the fact that ephrinB2 is localized on the luminal endothelial cell surface, 11, 13 we next investigated whether the elevated level of ephrinB2 in the aortic segments would facilitate the interaction with monocytes under proarteriosclerotic flow conditions (ie, zero to low laminar flow). Adhesion of suspended THP-1 cells to the ephrinB2-rich mouse aorta ( Figure 4A and 4B) and the ephrinB2-poor second-order branch of the mouse mesenteric artery (Figure 4C and 4D ) was markedly different, with many more monocytes sticking to the aortic segment ( Figure 4E ; Figure 4F and 4H). This adhesiveness seemed to be mainly due to ephrinB2-EphB interaction, as it was virtually abolished following blocking of the THP-1 cell EphB receptors with soluble ephrinB2 (Figure 4E ; Figure 4F and 4G). Likewise, adhesion of THP-1 cells was inhibited by pretreating the aorta with soluble monomeric EphB4, which specifically blocks endothelial cell ephrinB2 (Figure 4M ; Figure 4K and 4L).
Next, we determined whether endothelial cell ephrinB2 forward signaling is sufficient to activate the monocytes. To this end, THP-1 cells were exposed to porcine aortic endo- thelial cells overexpressing a truncated human ephrinB2 variant that cannot reciprocally activate the endothelial cell because of the lack of a cytoplasmic domain. In line with the aforementioned results, exposure to endothelial cell ephrinB2 significantly upregulated MCP-1 and IL-8 expression by the monocytes ( Figure 4N ). Consequently, we studied the impact of an elevated endothelial cell ephrinB2 expression on macrophage infiltration in arteriosclerotic plaques ex vivo. Spontaneously developing arteriosclerotic lesions in ApoEdeficient mice show quite variable levels of endothelial cell ephrinB2. Therefore, they were divided into 2 groups, representing plaques with either low or high ephrinB2 abundance. Although such an ephrinB2 status can reflect only a snapshot of plaque development, lesions with endothelial cells abundantly expressing ephrinB2 contained significantly more macrophages than their low ephrinB2-expressing counterparts (compare Figure 5A and 5C with Figure 5B , 5D, and 5G). Most but not all of the plaque-associated macrophages expressed EphB receptors (eg, EphB2, EphB4), a pattern that appears to be independent of the ephrinB2 expression level in endothelial cells (Supplemental Figure VII) .
Discussion
EphrinB2 as a New Marker of Pathophysiological Arterial Remodeling
The membrane-bound ligand ephrinB2 has been credited as the first arterial marker molecule 2 determining the differentiation of arterial endothelial cells 22 and driving organization of the capillary architecture during angiogenesis. 7 In this context, several environmental factors have been described that control its expression, including vascular endothelial growth factor and hypoxia. 13, 23 Moreover, hemodynamic factors affect endothelial cell ephrinB2 expression, which is elevated by reduced (laminar) shear stress and increased (cyclic) stretch. 11, 14 Circumferential wall tension (hence, stretch) is an important molding force for several pathophysiologically relevant remodeling processes, such as hypertension-induced thickening of the vessel wall, arteriosclerosis, and arteriogenesis. The latter denotes an adaptive remodeling process of collateral arterioles to form small arteries that is accompanied by a marked rise in ephrinB2 expression in the arteriolar endothelial cells. 11, 24 As a new but complementary finding, we here demonstrate that endothelial cell ephrinB2 expression is increased at arteriosclerosis predilection sites of the mouse vasculature, ie, at bifurcations and curvatures, 25, 26 which may also be amplified by hypertension. At these sites, the turbulent rather than laminar profile of the flowing blood and the reflections of the pulse wave result in a major change of the biomechanical forces acting on the arterial vessel wall. 27, 28 Although the unidirectional (laminar) shear stress is not only nullified but rather becomes oscillatory, pulsatile alterations in circumferential wall tension are accentuated. Both factors are likely to contribute to cyclic stretching of the endothelial cells. These altered hemodynamics favor endothelial dysfunction, ie, a phenotypic shift of the endothelial cell from an antiinflammatory to a proinflammatory state. Among other effects, this is caused by a decreased bioavailability of nitric oxide triggering the site-specific expression of, eg, adhesion molecules, such as E-selectin, intercellular adhesion molecule-1, or vascular cell adhesion molecule-1. 29 In combination with the low to zero flow conditions at the vessel wall, the adhesive properties of the endothelial cells thus facilitate the recruitment of monocytes, which in turn become activated, infiltrate the vessel wall, and contribute to early lesion formation. 15, 30 Even though ephrinB2 may impart some proadhesive properties with respect to endothelial cell-monocyte interaction, it is important to note that it is unlikely to act as an adhesion molecule per se, as it does not induce rolling monocytes to firmly adhere to the endothelial cell surface under physiological flow conditions. 31 In fact, analysis of the interaction between ephrinB2-overexpressing endothelial cells and THP-1 cells-a cell line that resembles the properties of human monocytes-under venous flow conditions (1 dyne/cm 2 ) revealed no contribution of the ephrin/Eph system to monocyte adhesion (data not shown).
Otherwise, there is most likely no physiological flow at arterial bifurcations or curvatures, so endothelial cell ephrinB2 may nonetheless contribute to the adhesion molecule-mediated recruitment and activation of the monocytes. This hypothesis is strengthened by our finding that the elevated expression of ephrinB2 in the endothelial cell monolayer of arteriosclerotic lesions correlates with an increased abundance of macrophages in the neointima. An elevated level of endothelial cell ephrinB2 expression may thus be regarded as a marker for a pathophysiologically relevant arterial remodeling process.
Interaction With EphrinB2 Affects Monocyte Activity
Contact of the monocytes with ephrinB2 has been shown to affect their migratory activity 11, 12 (Supplemental Figure II) . Directed migration of adhering monocytes to the nearest endothelial cell-cell junction is a hallmark of the transmigration process and guided by specific interactions of adhesion molecules comprising CD11 to CD18, intercellular adhesion molecule-1, and intercellular adhesion molecule-2. 32 EphrinB2 also affects the transmigration of monocytes through the endothelial cell monolayer as evidenced by an increased number of monocytes being lodged in interendothelial cell junctions during diapedesis on blockade of ephrinB/EphB interaction. 11, 12 This behavior resembles the phenotype of (endothelial) CD31 or platelet/endothelial cell adhesion molecule-1 deficiency 33, 34 and coincides with the fact that ephrinB2 associates context-dependently with CD31. 13 Nonetheless, it remains to be elucidated (although doing so will be technically demanding) by which mechanism endothelial cell ephrinB2 affects monocyte transmigration and whether the different EphB receptor subtypes expressed by these cells are simply a matter of redundancy or exert specific functional effects. Because of its upregulation on monocyte differentiation into macrophages, EphB2 is likely to play a role in transducing ephrinB2-mediated signals into these cells.
The Expression of Proarteriosclerotic Gene Products by Monocytes Is Triggered by EphrinB2
Another important aspect of endothelial cell-dependent stimulation of circulating leukocytes is their release of chemokines, which usually links the transmigration event to further steps of a specific proinflammatory cascade. This is realized through distinct and corresponding ligand-receptor systems located on the surface of both cell types. Binding of monocyte lymphocyte function-associated antigen 1 (LFA-1) to endothelial cell intercellular adhesion molecule-1 thus induces macrophage inflammatory protein (MIP-1␣) expression in the monocytes, 35 and transmigration of CD40-positive monocytes through an endothelial cell monolayer expressing the corresponding ligand, CD154, stimulates IL-1␤ expression in the transmigrating monocytes. 36 As a new and hitherto unknown function, we here show that in addition to the stimulatory effect on monocyte migration, clustered or endothelial cell-associated ephrinB2 induces monocyte MCP-1 and IL-8 expression, thus promoting their proinflammatory differentiation. MCP-1 or CCL2 has long been known as a proarteriosclerotic molecule that is expressed by resident cells of the vessel wall, as well as by infiltrating leukocytes. 37 IL-8 is expressed in macrophages from arteriosclerotic plaques, and this seems to be amplified by cholesterol loading of these cells. 38, 39 Although originally described as a chemokine specifically causing neutrophil activation and migration, 40 there is increasing evidence that IL-8 also boosts the accumulation of macrophages in arteriosclerotic lesions. 41 In fact, both MCP-1 and IL-8 contribute to arteriosclerotic lesion formation in the mouse aorta and trigger firm adhesion of monocytes to the endothelial cell monolayer, whereas related chemokines have no such effects. 42 An ephrinB2-mediated release of MCP-1 and IL-8 from monocytes or macrophages may thus reinforce the recruitment of monocytes, as well as other leukocytes, into the early plaque, thereby fuelling its growth into a complicated lesion. 43, 44 In conclusion, our results suggest that (1) ephrinB2 physically interacts with compatible EphB receptors that are constitutively expressed by monocytes and in part upregulated on their differentiation into macrophages; (2) that the abundance of this ligand in adult endothelial cells is sitespecifically regulated, with the most prominent expression at arteriosclerosis-prone sites of the arterial tree; and (3) that ephrin B2-EphB interaction promotes expression of proarteriosclerotic gene products by the monocytes contributing to progression of the disease. These findings substantiate the notion that ephrinB2 exerts certain immunomodulatory effects during pathophysiological vascular remodeling processes, thus clearly surpassing its role as a mere marker of arterial endothelial cells.
